NCT00746642 Use of Mellitor Sensor for Continuous Glucose Monitoring - An Ex-Vivo Study Status UNKNOWN Phase NA
NCT00741702 Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples Status COMPLETED Phase NA
NCT00741026 A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers Status COMPLETED Phase NA
NCT00737880 Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation Status COMPLETED Phase PHASE4
NCT00732602 The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes Status COMPLETED Phase NA
NCT00732407 Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM) Status UNKNOWN Phase NA
NCT00727857 Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT00722917 Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE2
NCT00721552 Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome Status COMPLETED Phase NA
NCT00718198 Effects of a Computerized Physician Order Entry (CPOE)-Based Inpatient Insulin Protocol on Glycemic Outcomes Status COMPLETED Phase N/A
NCT00717288 Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir Status COMPLETED Phase PHASE4
NCT00708604 Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT00707993 Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics Status COMPLETED Phase PHASE3
NCT00707447 Evaluation of a Primary Type 2 Diabetes Prevention Programme Status COMPLETED Phase PHASE4
NCT00706420 Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00705536 Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20 Status COMPLETED Phase PHASE1